Skip to main content
Livermore
Livermore
ZHEN

Amundi

SEC CIK
0001330387
Latest filing
Aug 26, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
2,579,748
Value
$233.4M
% of portfolio
0.1%
Quarters held
21
Since Q2 2021
Holdings of EW by Amundi, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,579,748$233.4M0.1%−90,461−3.4%ReducedHolders
Q1 20262,670,209$213.8M0.1%+12,171+0.5%AddedHolders
Q4 20252,658,038$226.6M0.1%+5,076+0.2%AddedHolders
Q3 20252,652,962$203.1M0.1%−808,167−23.3%ReducedHolders
Q2 20253,461,129$266.6M0.1%+541,943+18.6%AddedHolders
Q1 20252,919,186$213.0M0.1%−402,011−12.1%ReducedHolders
Q4 20243,321,197$246.3M0.1%−161,211−4.6%ReducedHolders
Q3 20243,482,408$238.6M0.1%−1,735,109−33.3%ReducedHolders
Q2 20245,217,517$475.6M0.2%−302,340−5.5%ReducedHolders
Q1 20245,519,857$480.1M0.2%−710,696−11.4%ReducedHolders
Q4 20236,230,553$472.6M0.2%+318,902+5.4%AddedHolders
Q3 20235,911,651$418.0M0.2%−1,498,503−20.2%ReducedHolders
Q2 20237,410,154$679.1M0.3%+914,993+14.1%AddedHolders
Q1 20236,495,161$541.7M0.3%−1,613,687−19.9%ReducedHolders
Q4 20228,108,848$629.0M0.3%+1,673,580+26.0%AddedHolders
Q3 20226,435,268$561.5M0.3%+1,154,632+21.9%AddedHolders
Q2 20225,280,636$511.3M0.4%−47,911−0.9%ReducedHolders
Q1 20225,328,547$657.9M0.4%+881,088+19.8%AddedHolders
Q4 20214,447,459$537.8M0.3%−351,962−7.3%ReducedHolders
Q3 20214,799,421$543.3M0.4%+29,607+0.6%AddedHolders
Q2 20214,769,814$494.0M0.3%–No prior filingHolders